Obese individuals with kidney tumors are 48% more likely to develop a clear-cell renal cell carcinoma (RCC) than non-obese individuals, researchers reported in BJU International (2010;105:16-20).
The risk increases by 4% for each one-point increment in BMI.
Investigators at Memorial Sloan-Kettering Cancer Center in New York evaluated 1,640 patients with kidney tumors, of which 88% were malignant. Nearly two-thirds of the malignancies were clear-cell RCC. Overall, 38% of the subjects were obese (BMI of 30 kg/m2 or more).
Continue Reading
Of the clear-cell RCC patients, 42% were obese compared with only 31% of patients with benign tumors. The analysis also showed that 67% of obese patients had malignant tumors with clear-cell RCC compared with 57% of non-obese patients.
The authors concluded that BMI is an independent predictor of clear-cell RCC.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.